CORRECTION article

Front. Cell Dev. Biol., 15 November 2023

Sec. Cell Adhesion and Migration

Volume 11 - 2023 | https://doi.org/10.3389/fcell.2023.1239836

Corrigendum: miR-766-3p targeting BCL9L suppressed tumorigenesis, epithelial-mesenchymal transition, and metastasis through the β-catenin signaling pathway in osteosarcoma cells

  • 1. Department of Orthopedics, First Affiliated Hospital of Nanjing Medical University, Nanjing, China

  • 2. Department of Respiratory and Critical Care Medicine, First Affiliated Hospital of Nanjing Medical University, Nanjing, China

  • 3. Department of Orthopedics, The Affiliated Zhongda Hospital of Southeast University, Nanjing, China

  • 4. Department of Pain Management, Sir Run Run Hospital, Nanjing Medical University, Nanjing, China

Article metrics

View details

1

Citations

1k

Views

431

Downloads

In the published article, there was an error in Figure 2 as published. The photograph of U2OS N-cadherin WB strip in Figure 2B, the 143B miR-766-3p sh#2 cell migration and invasion photograph of Figures 2E, G are wrong. The corrected Figure 2 and its caption appear below.

FIGURE 2

FIGURE 2

Downregulating miR-766-3p promoted OS cell EMT, migration and invasion in vitro. (A) miR-766-3p lentiviruses were successfully transfected into 143B and U2OS cell lines (n = 3). (B) miR-766-3p sh#1 and miR-766-3p sh#2 increased the expression level of metastasis-related proteins in 143B and U2OS (n = 3). (C–F) The knockdown of miR-766-3p notably promoted the invasion and migration of 143B and U2OS cells (n = 4). (G, H) The Transwell invasion assays indicated that the knockdown of miR-766-3p significantly increased the invasive ability of OS cells (n = 4). (I–K) Colony formation, CCK-8 and EdU assays demonstrated that downregulating miR-766-3p promoted the proliferation of OS cells (n = 4). Data are presented as the means ± SD. *p < 0.01.

The authors apologize for these errors and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.

Statements

Publisher’s note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

Summary

Keywords

osteosarcoma, miR-766-3p, BCL9L, β-catenin, EMT, metastasis

Citation

Zhang S, Chen H, Liu W, Fang L, Qian Z, Kong R, Zhang Q, Li J and Cao X (2023) Corrigendum: miR-766-3p targeting BCL9L suppressed tumorigenesis, epithelial-mesenchymal transition, and metastasis through the β-catenin signaling pathway in osteosarcoma cells. Front. Cell Dev. Biol. 11:1239836. doi: 10.3389/fcell.2023.1239836

Received

14 June 2023

Accepted

27 October 2023

Published

15 November 2023

Volume

11 - 2023

Edited and reviewed by

Maurizio Onisto, University of Padua, Italy

Updates

Copyright

*Correspondence: Juming Li, ; Xiaojian Cao,

†These authors have contributed equally to this work

Disclaimer

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

Outline

Figures

Cite article

Copy to clipboard


Export citation file


Share article

Article metrics